GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » EV-to-Revenue

VIVUS (STU:VIU1) EV-to-Revenue : 0.04 (As of May. 15, 2024)


View and export this data going back to . Start your Free Trial

What is VIVUS EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, VIVUS's enterprise value is €2.66 Mil. VIVUS's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was €65.89 Mil. Therefore, VIVUS's EV-to-Revenue for today is 0.04.

The historical rank and industry rank for VIVUS's EV-to-Revenue or its related term are showing as below:

STU:VIU1's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.97
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), VIVUS's stock price is €0.06. VIVUS's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was €6.19. Therefore, VIVUS's PS Ratio for today is 0.01.


VIVUS EV-to-Revenue Historical Data

The historical data trend for VIVUS's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS EV-to-Revenue Chart

VIVUS Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 0.74 0.96 3.18 3.43

VIVUS Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.39 3.30 3.38 3.43 3.38

Competitive Comparison of VIVUS's EV-to-Revenue

For the Biotechnology subindustry, VIVUS's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VIVUS's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where VIVUS's EV-to-Revenue falls into.



VIVUS EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

VIVUS's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.662/65.887
=0.04

VIVUS's current Enterprise Value is €2.66 Mil.
VIVUS's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €65.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VIVUS  (STU:VIU1) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

VIVUS's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.06/6.19
=0.01

VIVUS's share price for today is €0.06.
VIVUS's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VIVUS EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of VIVUS's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


VIVUS (STU:VIU1) Business Description

Traded in Other Exchanges
N/A
Address
900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines